The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG-GI002: A phase II clinical trial platform for total neoadjuvant therapy (TNT) in rectal cancer.
 
Thomas J. George
Consulting or Advisory Role - Bayer; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst)
 
Greg Yothers
Employment - Mountainview Pediatrics (I)
Consulting or Advisory Role - Orbus Therapeutics; Pharmacyclics
 
Theodore S. Hong
Research Funding - Novartis (Inst); Taiho Pharmaceutical
 
Marcia McGory Russell
Honoraria - American College of Surgeons; Healthgrades
Consulting or Advisory Role - American College of Surgeons; Healthgrades
 
Y. Nancy You
No Relationships to Disclose
 
William Parker
No Relationships to Disclose
 
Samuel A. Jacobs
No Relationships to Disclose
 
Katherine L. Pogue-Geile
Patents, Royalties, Other Intellectual Property - The following patent was submitted U. S. Patent Application Serial No. 14/738,757 entitled “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin amd published on 12/24/15
 
Christina Sing-Ying Wu
Honoraria - BioTheranostics
Consulting or Advisory Role - Bayer
Research Funding - Amgen
Travel, Accommodations, Expenses - Merck
 
Namrata Vijayvergia
Consulting or Advisory Role - Lexicon (Inst)
Research Funding - Merck (Inst)
 
Norman Wolmark
Research Funding - Abbvie (Inst); Bayer (Inst); Puma Biotechnology (Inst)